Tavapadon Marches on in Parkinson’s Disease
PHILADELPHIA — Tavapadon, an experimental first-in-class oral selective partial D1/D5 dopamine receptor agonist for Parkinson's disease ...
Read more
Tag: Tavapadon
Get the latest Health and Fitness News on YourFitnessNewsToday.com.
Wellbeing tips, weight Loss, workouts, and more...